Clinical trial
An Open-Label Long-term Safety Study of Tramadol HCl OAD (Once A Day) 300 mg in the Treatment of Pain Due to Osteoarthritis of the Knee
NCT00833911 is registered in ClinicalTrials.gov with Labopharm Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label Long-term Safety Study of Tramadol HCl OAD (Once A Day) 300 mg in the Treatment of Pain Due to Osteoarthritis of the Knee
- Lead sponsor
- Labopharm Inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 30, 2003
- Completion date
- July 31, 2004
- Enrollment
- 392 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.